+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Statin Use during Hospitalization and Short-Term Mortality in Acute Ischaemic Stroke with Chronic Kidney Disease



Statin Use during Hospitalization and Short-Term Mortality in Acute Ischaemic Stroke with Chronic Kidney Disease



European Neurology 79(5-6): 296-302



Statin use during hospitalization improves prognosis in patients with ischaemic stroke. However, it remains uncertain whether acute ischaemic stroke patients with chronic kidney disease (CKD) benefit from statin therapy. We investigated the effect of statin use during hospitalization in reducing short-term mortality of patients with ischaemic stroke and CKD. Data of first-ever ischaemic stroke patients without a history of pre-stroke statin treatment was derived from the China National Stroke Registry. Patients were stratified according to estimated glomerular filtration rate (eGFR): normal renal function (eGFR ≥90 mL/min/1.73 m2), mild CKD (eGFR 60-90 mL/min/1.73 m2) and moderate CKD (eGFR < 60 mL/min/1.73 m2). Multivariate logistic regression analysis was used to evaluate the association between statin use during hospitalization and all-cause mortality with different renal functions at 3-month follow-up. Among 5,951 patients included, 2,595 (43.6%) patients were on statin use during hospitalization after stroke (45.7% in patients with normal renal function, 42.0% in patients with mild CKD, and 39.0% in patients with moderate CKD). Compared with the non-statin group, statin use during hospitalization was associated with decreased all-cause mortality in patients with normal renal function (OR 0.65, 95% CI 0.43-0.97, p = 0.04), mild CKD (OR 0.59, 95% CI 0.38-0.91, p = 0.02) and moderate CKD (OR 0.41, 95% CI 0.23-0.75, p = 0.004) at 3-month follow-up. Statin use during hospitalization was associated with decreased 3-month mortality of ischaemic stroke patients with mild and moderate CKD. However, the conclusion should be confirmed in further studies with larger population, especially with moderate CKD.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065532814

Download citation: RISBibTeXText

PMID: 29852478

DOI: 10.1159/000488402


Related references

Short-term statin therapy for prevention of contrast induced-acute kidney injury in patients with diabetes and chronic kidney disease. European Heart Journal 34(Suppl 1): 1946-1946, 2013

Micro-albuminuria: a predictor of short-term mortality in acute ischaemic stroke. Journal of the Indian Medical Association 106(12): 783-4, 786, 2009

Prescription of anti-oedema agents and short-term mortality in older patients with acute ischaemic stroke. Drugs and Aging 21(4): 273-278, 2004

Prescription of Anti- Oedema Agents and Short-Term Mortality in Older Patients with Acute Ischaemic Stroke. Drugs & Aging 21(4): 273-278, 2004

Short-term and long-term effects of acute kidney injury in chronic kidney disease patients: A longitudinal analysis. Biometrical Journal. Biometrische Zeitschrift 58(6): 1552-1566, 2016

Ischaemic stroke subtypes had different short term and long term functional outcomes, mortality, and recurrence rates. Evidence-Based Medicine 6(1): 26-26, 2001

Statin use and hospitalization for sepsis in patients with chronic kidney disease. JAMA (Journal of the American Medical Association) 297(13): 1455-1464, 2007

Significant variation in mortality and functional outcome after acute ischaemic stroke between Western countries: data from the tinzaparin in acute ischaemic stroke trial (TAIST). Journal of Neurology, Neurosurgery, and Psychiatry 77(3): 327-333, 2005

Combination of acute stroke unit and short-term stroke ward with early supported discharge decreases mortality and complications after acute ischemic stroke. Journal of the Medical Association of Thailand 90(6): 1089-1096, 2007

Are pre-existing markers of chronic kidney disease associated with short-term mortality following acute community-acquired pneumonia and sepsis? A cohort study among older people with diabetes using electronic health records. Nephrology, Dialysis, Transplantation 30(6): 1002-1009, 2015

Ischaemic stroke, haemorrhage, and mortality in older patients with chronic kidney disease newly started on anticoagulation for atrial fibrillation: a population based study from UK primary care. BMJ 360: K342, 2018

Statin use and hospitalization for sepsis in patients with chronic kidney disease (vol 297, pg 1455, 2007). 2008

Predictors of short- and long-term mortality in first-ever ischaemic older stroke patients. Australasian Journal on Ageing 32(4): 229-232, 2014

Influence of Statin Pretreatment on Initial Neurological Severity and Short-Term Functional Outcome in Acute Ischemic Stroke Patients: The Fukuoka Stroke Registry. Cerebrovascular Diseases 42(5-6): 395-403, 2016

Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality. American Heart Journal 156(2): 277-283, 2008